VYZULTA
Google image searchProduct monograph
Active ingredient
latanoprostene bunod, 0.024 %/W/V
DIN: 02484218
Dosage form(s): SOLUTION
Route(s) of administration: OPHTHALMIC
Schedule: Prescription
Company: BAUSCH & LOMB INC
Date: 17-MAY-2019
ATC:
- S01 — OPHTHALMOLOGICALS (ATC, ATC/DDD, )
- S01E — ANTIGLAUCOMA PREPARATIONS AND MIOTICS (ATC, ATC/DDD)
- S01EE — Prostaglandin analogues (ATC, ATC/DDD)
- S01EE06 — LATANOPROSTENE BUNOD (ATC/DDD)
